Short Description
Quantitatively measures cytoplasmic AST (GOT1) levels in human serum, plasma, tissues, and cell lysates.
ADME Research Domain
Metabolism
Description
CytoFinal™ Human AST (GOT1) ELISA Kit enables highly sensitive and specific in vitro quantification of cytoplasmic Aspartate Aminotransferase in human biological samples. It supports reliable detection in serum, plasma, tissue homogenates, cell lysates, and culture supernatants, facilitating research across hepatology, oncology, and immunology.
Features
High-sensitivity detection of human cytoplasmic AST (GOT1) with a lower limit of 5.5 ng/mL for accurate measurements.
Excellent specificity ensures minimal cross-reactivity or interference from analogues, enhancing assay reliability across sample types.
Lyophilized standard format provides stability up to 12 months, supporting consistent results with proper storage and handling.
Sandwich ELISA format with colorimetric detection allows straightforward quantification and compatibility with standard laboratory equipment.
Process Relevance
Monitors cytoplasmic AST levels to assess liver function, cellular metabolism, and immune response in research studies.
Application Stage
Applicable in drug discovery, biomarker validation, and preclinical or clinical sample evaluation.
Applications
Suitable for ELISA-based assays in serum, plasma, tissue, cell lysates, or supernatants to quantify GOT1 and support downstream ADME profiling studies.
Target
Human cytoplasmic Aspartate Aminotransferase (AST, GOT1) protein
Detection Method
Colorimetric
Sample Type
Serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids.
Assay Measures
Quantitative
Research Areas
Enzymology, hepatology, tumor immunology, infection immunity, pharmacokinetics (ADME), cancer research, metabolic pathway studies, etc.